Inactive Instrument
Sector Plasmatech Biopharmaceuticals Inc Nasdaq
Stocks
US72754H1095
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 05/08 | Abeona Therapeutics Inc. Grants New Technology Add-On Payment Status For ZEVASKYN | CI |
| 29/06 | Abeona Therapeutics Inc.(NasdaqCM:ABEO) dropped from Russell 3000E Growth Benchmark | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1.20% | +2.44% | +15.53% | +10.17% | +1.21% | +39.56% | +0.84% | +27.25% | +85.55% | 77.1B | |
| -0.84% | +0.09% | -12.10% | -4.17% | -6.50% | +20.92% | +179.15% | +134.05% | +227.56% | 49.43B | |
| +2.77% | +1.90% | +10.75% | +5.14% | -8.20% | -1.84% | +27.14% | +10.12% | - | 49.27B | |
| -0.13% | +3.33% | +6.41% | +6.10% | -23.43% | -50.97% | -50.14% | -55.63% | +15.26% | 44.59B | |
| +0.12% | +1.81% | +0.45% | +7.97% | +17.41% | +61.74% | -23.82% | -39.26% | -34.12% | 30.48B | |
| +1.82% | +0.90% | +2.16% | +23.35% | +22.10% | +54.22% | +85.80% | +60.14% | +36.98% | 24B | |
| +8.39% | +6.48% | -26.82% | +20.26% | +97.94% | +119.36% | -42.32% | -87.95% | - | 21.5B | |
| +4.29% | +7.66% | +4.81% | +4.69% | +24.39% | -3.26% | +189.18% | +27.66% | - | 20.18B | |
| +1.66% | -3.70% | -5.54% | +2.03% | +36.18% | +65.40% | +123.91% | +159.71% | +317.31% | 16.29B | |
| +1.43% | +4.27% | +7.19% | +23.81% | +9.18% | +81.74% | +169.74% | +56.42% | - | 16.19B | |
| +3.92% | +41.86% | +19.79% | +9.08% | -11.79% | -9.78% | +761.96% | +422.86% | +6,265.22% | 14.37B | |
| +3.07% | +5.11% | +4.53% | +16.57% | +6.15% | +6.10% | -28.17% | -18.60% | -36.29% | 11.88B | |
| +1.06% | -2.65% | -15.03% | -3.63% | +16.20% | +103.43% | +198.52% | +675.37% | +2,656.10% | 10.81B | |
| +0.91% | -4.72% | -11.82% | +9.55% | +31.84% | +138.82% | +199.54% | +437.51% | - | 9.55B | |
| +0.69% | +2.12% | +12.51% | +11.13% | -4.91% | -20.79% | -20.88% | -51.52% | -47.46% | 6.95B | |
| +6.16% | +25.65% | +26.36% | +96.50% | +262.64% | +360.12% | +384.34% | +1.94% | - | 6.84B | |
| +2.18% | +2.64% | +3.88% | +17.80% | +2.38% | +8.28% | +64.52% | -3.68% | - | 6.01B | |
| -0.76% | +2.09% | +12.78% | +33.30% | +83.98% | +129.21% | +321.38% | +486.02% | - | 5.97B | |
| +9.98% | +19.22% | -18.38% | -6.83% | +14.28% | +31.81% | +255.50% | +245.22% | - | 5.67B | |
| Average | +2.54% | +2.24% | +1.97% | +14.88% | +30.05% | +59.69% | +147.17% | +130.93% | +948.61% | 22.48B | |
| Weighted average by Cap. | +1.81% | +2.78% | +3.16% | +9.92% | +12.79% | +36.27% | +88.82% | +71.26% | +495.02% |
- Stock Market
- Stocks
- ABEO Stock
- Stock
- Sector Plasmatech Biopharmaceuticals Inc
Select your edition
All financial news and data tailored to specific country editions
